Skip to main content
Fig. 2 | BMC Medical Research Methodology

Fig. 2

From: Comparing the use of aggregate data and various methods of integrating individual patient data to network meta-analysis and its application to first-line ART

Fig. 2

Network of evidence showing all treatments and the trial comparisons available in the evidence base. Legend: Circles (nodes) in the diagrams represent individual treatments, lines between circles represent availability of head-to-head evidence between two treatments, and the numbers on the lines are the number of RCTs informing each head-to-head comparison. Blue: NNRTIs; Green: Protease inhibitors; Orange: Integrase inhibitors. ATV/r: ritonavir-boosted atazanavir; DRV/r: ritonavir-boosted darunavir; DTG: dolutegravir; EFV: efavirenz; EFV400: efavirenz 400; EVG/c: elvitegravir/cobicistat; LPV/r: ritonavir-boosted lopinavir; NVP: nevirapine; RAL: raltegravir; RPV: rilpivirine; BIC: bictegravir; DOR: doravirine

Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us